Rapamycin-regulated control of antiangiogenic tumor therapy following rAAV-mediated gene transfer (Q40179808)

18 September 2017

Rapamycin-regulated control of antiangiogenic tumor therapy following rAAV-mediated gene transfer (English)

1 reference

18 September 2017

angiogenesis inhibitor

1 reference

Minh Nguyen

1

1 reference

18 September 2017

Guang Huan-Tu

2

1 reference

18 September 2017

Melissa Gonzalez-Edick

3

1 reference

18 September 2017

Victor M Rivera

4

1 reference

18 September 2017

Tim Clackson

5

1 reference

18 September 2017

Karin U Jooss

6

1 reference

18 September 2017

Thomas C Harding

7

1 reference

18 September 2017

23 January 2007

1 reference

18 September 2017

1 reference

18 September 2017

15

1 reference

18 September 2017

912-920

1 reference

18 September 2017

5

1 reference

Gene therapy progress and prospects: transcription regulatory systems.

18 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Regulatable gene expression systems for gene therapy applications: progress and future challenges

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Dimerizer-regulated gene expression

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer.

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Rapamycin control of transgene expression from a single AAV vector in mouse salivary glands

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Dimerizer regulation of AADC expression and behavioral response in AAV-transduced 6-OHDA lesioned rats

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates.

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Rapamycin for immunosuppression in organ allografting.

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Current development of mTOR inhibitors as anticancer agents

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Subthalamic GAD gene therapy in a Parkinson's disease rat model

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

The cryptic life style of adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Anti-tumor efficacy of human angiostatin using liver-mediated adeno-associated virus gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

VEGF-Trap: a VEGF blocker with potent antitumor effects

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Long-term regulated expression of growth hormone in mice after intramuscular gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer.

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Regulated expression of erythropoietin from an AAV vector safely improves the anemia of beta-thalassemia in a mouse model.

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Co-expression of human adenosine deaminase and multidrug resistance using a bicistronic retroviral vector

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins.

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Recognition of picornavirus internal ribosome entry sites within cells; influence of cellular and viral proteins

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye.

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

The cell-specific enhancer of the mouse transthyretin (prealbumin) gene binds a common factor at one site and a liver-specific factor(s) at two other sites

1 reference

https://api.crossref.org/works/10.1038%2FMT.SJ.6300079

7 January 2021

Identifiers

DOI

10.1038/MT.SJ.6300079

1 reference

18 September 2017

1 reference